4 news items
Ligand Reports First Quarter 2024 Financial Results
AMGN
CASI
JAZZ
7 May 24
litigation could expose Ligand to significant liabilities and have a material adverse effect on the company. The failure to meet expectations
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
AGEN
LGND
7 May 24
revenues we may receive. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
LGND
8 Apr 24
of this release. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMIâ„¢
LGND
3 Apr 24
provisions of the Private Securities Litigation Reform Act of 1995
- Prev
- 1
- Next